APA (7th ed.) Citation

H, Z., Y, Z., X, L., L, F., F, G., & Y, M. (2021). High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy. Frontiers in oncology, 11, 724250. https://doi.org/10.3389/fonc.2021.724250

Chicago Style (17th ed.) Citation

H, Zhang, Zhao Y, Liu X, Fu L, Gu F, and Ma Y. "High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy." Frontiers in Oncology 11 (2021): 724250. https://doi.org/10.3389/fonc.2021.724250.

MLA (9th ed.) Citation

H, Zhang, et al. "High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy." Frontiers in Oncology, vol. 11, 2021, p. 724250, https://doi.org/10.3389/fonc.2021.724250.